EUVIMEDEUVIMED entdecken
Crossref

Repurposing Sildenafil Using Reactive Oxygen Species-Responsive Silica-Cross-Linked Nanomicelles for the Attenuation of Myocardial Ischemia−Reperfusion Injury

Fang Zhang, Haoyi Yuan, Xueping Zeng, Keqiang Lu, Yunyun Zhou, Juanjuan Peng, Lingzhi Zhao

ACS Applied Nano Materials · 13.11.2026 · 9 (45) · 21229-21240

DOI: 10.1021/acsanm.6c03277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 29.10.2026. Verfasst von Fang Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Life Science and Technology Research Institute Co., Ltd.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reperfusion therapy is the standard treatment for acute myocardial infarction, yet it paradoxically induces myocardial ischemia−reperfusion injury (MI/RI), resulting in further cardiomyocyte loss. Effective therapies for MI/RI therefore remain a major unmet clinical need. Sildenafil, a clinically approved phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction and pulmonary arterial hypertension, has shown potential cardioprotective activity through the enhancement of nitric oxide−cyclic guanosine monophosphate (NO−cGMP) signaling and vasodilation. However, its therapeutic utility in MI/RI is limited by nonspecific biodistribution and insufficient accumulation at the site of injury. Here, we developed a reactive oxygen species-responsive, silica-cross-linked micellar nanoplatform for systemic sildenafil delivery. This nanoplatform promotes preferential accumulation in the infarcted myocardium and enables ROS-triggered drug release within the pathological microenvironment. In a rat model of MI/RI, intravenous administration of the nanomedicine significantly improved cardiac function, reduced apoptosis and fibrosis, and markedly alleviated myocardial injury. These findings highlight a promising therapeutic strategy for MI/RI and support the expanded clinical application of sildenafil.

Förderung

  • National Natural Science Foundation of China
  • Beijing Life Science and Technology Research Institute Co., Ltd

Zitieren

APA

Zhang, F., Yuan, H., Zeng, X., Lu, K., Zhou, Y., Peng, J., & Zhao, L. (2026). Repurposing Sildenafil Using Reactive Oxygen Species-Responsive Silica-Cross-Linked Nanomicelles for the Attenuation of Myocardial Ischemia−Reperfusion Injury. ACS Applied Nano Materials, 9(45), 21229-21240. https://doi.org/10.1021/acsanm.6c03277

Vancouver

Zhang F, Yuan H, Zeng X, Lu K, Zhou Y, Peng J, et al. Repurposing Sildenafil Using Reactive Oxygen Species-Responsive Silica-Cross-Linked Nanomicelles for the Attenuation of Myocardial Ischemia−Reperfusion Injury. ACS Applied Nano Materials. 2026;9(45):21229-21240. doi:10.1021/acsanm.6c03277

BibTeX
@article{Zhang2026,
  author = {Zhang, Fang and Yuan, Haoyi and Zeng, Xueping and Lu, Keqiang and Zhou, Yunyun and Peng, Juanjuan and Zhao, Lingzhi},
  title = {Repurposing Sildenafil Using Reactive Oxygen Species-Responsive Silica-Cross-Linked Nanomicelles for the Attenuation of Myocardial Ischemia−Reperfusion Injury},
  journal = {ACS Applied Nano Materials},
  year = {2026},
  volume = {9},
  number = {45},
  pages = {21229--21240},
  doi = {10.1021/acsanm.6c03277}
}
Kostenlos starten →